Effectiveness of multidisciplinary care for Parkinson's disease: A randomized, controlled trial

被引:104
|
作者
van der Marck, Marjolein A. [1 ]
Bloem, Bastiaan R. [2 ]
Borm, George F. [3 ]
Overeem, Sebastiaan [2 ]
Munneke, Marten [1 ,4 ]
Guttman, Mark [5 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Evidence Based Practice, Dept Neurol, NL-6525 ED Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-6525 ED Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & HTA, NL-6525 ED Nijmegen, Netherlands
[4] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Evidence Based Practice, Sci Inst Qual Healthcare, NL-6525 ED Nijmegen, Netherlands
[5] Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada
关键词
Parkinson disease; randomized; controlled trial; quality of life; multidisciplinary care; patient care team; QUALITY-OF-LIFE; MEMORY CLINICS; REHABILITATION; THERAPY; PEOPLE; HEALTH; INTERVENTIONS; QUESTIONNAIRE; STIMULATION; PROGRESSION;
D O I
10.1002/mds.25194
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Multidisciplinary care is considered an optimal model to manage Parkinson's disease (PD), but supporting evidence is limited. We performed a randomized, controlled trial (RCT) to establish whether a multidisciplinary/specialist team offers better outcomes, compared to stand-alone care from a general neurologist. Patients with PD were randomly allocated to an intervention group (care from a movement disorders specialist, PD nurses, and social worker) or a control group (care from general neurologists). Both interventions lasted 8 months. Clinicians and researchers were blinded for group allocation. The primary outcome was the change in quality of life (Parkinson's Disease Questionnaire; PDQ-39) from baseline to 8 months. Other outcomes were the UPDRS, depression (Montgomery-Asberg Depression Scale; MADRS), psychosocial functioning (Scales for Outcomes in Parkinson's disease-Psychosocial; SCOPA-PS), and caregiver strain (Caregiver Strain Index; CSI). Group differences were analyzed using analysis of covariance adjusted for baseline values and presence of response fluctuations. A total of 122 patients were randomized and 100 completed the study (intervention, n = 51; control, n = 49). Compared to controls, the intervention group improved significantly on PDQ-39 (difference, 3.4; 95% confidence interval [CI]: 0.56.2) and UPDRS motor scores (4.1; 95% CI: 0.87.3). UPDRS total score (5.6; 95% CI: 0.910.3), MADRS (3.7; 95% CI: 1.45.9), and SCOPA-PS (2.1; 95% CI: 0.53.7) also improved significantly. This RCT gives credence to a multidisciplinary/specialist team approach. We interpret these positive findings cautiously because of the limitations in study design. Further research is required to assess teams involving additional disciplines and to evaluate cost-effectiveness of integrated approaches. (c) 2012 Movement Disorder Society
引用
收藏
页码:605 / 611
页数:7
相关论文
共 50 条
  • [31] The evidence for multidisciplinary care in Parkinson's disease
    Lidstone, Sarah C.
    Bayley, Mark
    Lang, Anthony E.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2020, 20 (06) : 539 - 549
  • [32] Multidisciplinary care for patients with Parkinson's disease
    van der Marck, M. A.
    Kalf, J. G.
    Sturkenboom, I. H. W. M.
    Nijkrake, M. J.
    Munneke, M.
    Bloem, B. R.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S219 - S223
  • [33] Patient Education for Patients with Parkinson's Disease - A Randomized Controlled Trial
    Magdalena, Chlond
    Felicitas, Bergmann
    Heike, Schnoor
    Karla, Eggert
    Astrid, Larisch
    ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE, 2013, 59 (01): : 68 - 69
  • [34] Caffeine as a treatment for Parkinson's disease: A randomized controlled trial (CafePD)
    Postuma, R.
    Anang, J.
    Pelletier, A.
    Moscovich, M.
    Grimes, D.
    Borys, A.
    Furtado, S.
    Munhoz, R.
    Cresswell, S.
    Moro, A.
    Hobson, D.
    Joseph, L.
    Lang, A.
    MOVEMENT DISORDERS, 2017, 32
  • [35] Randomized controlled trial of the Alexander Technique for idiopathic Parkinson's disease
    Stallibrass, C
    Sissons, P
    Chalmers, C
    CLINICAL REHABILITATION, 2002, 16 (07) : 695 - 708
  • [36] Speech treatment in Parkinson's disease: Randomized controlled trial (RCT)
    Ramig, Lorraine
    Halpern, Angela
    Spielman, Jennifer
    Fox, Cynthia
    Freeman, Katherine
    MOVEMENT DISORDERS, 2018, 33 (11) : 1777 - 1791
  • [37] A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease
    Shoulson, I
    Penney, J
    McDermott, M
    Kieburtz, K
    Schwid, SR
    Kayson, E
    Chase, T
    Fahn, S
    Greenamyre, JT
    Lang, A
    Siderowf, A
    Pearson, N
    Harrison, M
    Rost-Ruffner, E
    Colcher, A
    Lloyd, M
    Matthews, M
    Pahwa, R
    McGuire, D
    Lew, MF
    Schuman, S
    Marek, K
    Broshjeit, S
    Factor, S
    Brown, D
    Feigin, A
    Mazurkiewicz, J
    Ford, B
    Jennings, D
    Dillon, S
    Comella, C
    Blasucci, L
    Janko, K
    Shulman, L
    Wiener, W
    Bateman-Rodriguez, D
    Carrion, A
    Suchowersky, O
    Lafontaine, AL
    Pantella, C
    Siemers, E
    Belden, J
    Davies, R
    Lannon, M
    Grimes, D
    Gray, P
    Martin, W
    Kennedy, L
    Adler, C
    Newman, S
    NEUROLOGY, 2001, 56 (04) : 455 - 462
  • [38] Effects of cognitive training in Parkinson's disease: A randomized controlled trial
    Petrelli, Annette
    Kaesberg, Stephanie
    Barbe, Michael T.
    Timmermann, Lars
    Fink, Gereon R.
    Kessler, Josef
    Kalbe, Elke
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (11) : 1196 - 1202
  • [39] Randomized Controlled Trial of Memantine in Dementia Associated with Parkinson's Disease
    Leroi, Iracema
    Overshott, Ross
    Byrne, E. Jane
    Daniel, Emily
    Burns, Alistair
    MOVEMENT DISORDERS, 2009, 24 (08) : 1217 - 1221
  • [40] Randomized-placebo controlled trial of donepezil in Parkinson's disease
    Leroi, I.
    Brandt, J.
    Reich, S. G.
    Lyketsos, C. G.
    Grill, S.
    Thompson, R.
    Marsh, L.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 248 (1-2) : 289 - 290